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Summary statement 14 
We show that the chromatin remodeler Hmga1 has two distinct functions in 15 
neural crest development: first, it is critical for neural crest specification at the neural 16 
plate border via regulation of Pax7 expression; later, it mediates neural crest emigration 17 
in a Wnt-dependent manner. 18 
 19 
Abstract 20 
During gastrulation, neural crest cells are specified at the neural plate border, as 21 
characterized by Pax7 expression. Using single-cell RNA sequencing coupled with high 22 
resolution in situ hybridization to identify novel transcriptional regulators, we show that 23 
chromatin remodeler Hmga1 is highly expressed prior to specification and maintained in 24 
migrating chick neural crest cells. Temporally-controlled CRISPR-Cas9-mediated 25 
knockouts uncovered two distinct functions of Hmga1 in neural crest development. At 26 
the neural plate border, Hmga1 regulates Pax7-dependent neural crest lineage 27 
specification. At premigratory stages, a second role manifests where Hmga1 loss 28 
reduces cranial crest emigration from the dorsal neural tube independent of Pax7.  29 
Interestingly, this is rescued by stabilized ß-catenin, thus implicating Hmga1 as a 30 
canonical Wnt activator. Together, our results show that Hmga1 functions in a bimodal 31 
manner during neural crest development to regulate specification at the neural plate 32 
border, and subsequent emigration from the neural tube via canonical Wnt signaling.  33 
 34 
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Introduction 37 
The neural crest is a vertebrate-specific stem cell population with the capacity to 38 
migrate long distances during embryonic development (Bronner and LeDouarin, 2012; 39 
Le Douarin, 1980; Simões-Costa and Bronner, 2013). Originating at the neural plate 40 
border, these cells occupy the leading edges of the closing neural folds during 41 
neurulation. Subsequently, premigratory neural crest cells that initially reside within the 42 
dorsal aspect of the developing neural tube undergo an epithelial-to-mesenchymal 43 
(EMT) transition in order to delaminate and migrate extensively. Upon reaching their 44 
terminal locations within the embryo, neural crest cells differentiate into a plethora of 45 
derivatives, including craniofacial cartilage, pigment cells, smooth muscle, and 46 
peripheral neurons and glia (reviewed in Gandhi and Bronner, 2018). 47 
A feed-forward gene regulatory network (GRN) underlies the formation of the 48 
neural crest, from induction at the neural plate border to final differentiation into a 49 
multitude of cell types. This GRN is comprised of transcription factors and signaling 50 
pathways, partitioned into developmental modules (Martik and Bronner, 2017; Simões-51 
Costa and Bronner, 2015). Recently, new tools like single-cell RNA sequencing 52 
(scRNA-seq) and Assay for Transposase-Accessible Chromatin using sequencing 53 
(ATAC-seq) have enabled analysis of the neural crest GRN at a global level, helping to 54 
clarify lineage trajectories and elucidate key biological processes therein, ranging from 55 
proliferation to differentiation (Williams et al., 2019). These approaches have opened 56 
the way to extensive functional analysis of important nodes within the GRN, particularly 57 
at early stages of neural crest development, which are less well-studied.  58 
Neural crest formation begins at the gastrula stage, with establishment of the 59 
presumptive neural ectoderm bordering the non-neural ectoderm. Quantitative gene 60 
expression analysis of gastrula stage chick embryos has revealed a surprisingly high 61 
degree of overlap of multiple transcription factors associated with diverse cell types 62 
within single cells in the early neural plate border region, ranging from markers 63 
characteristic of the neural crest (Pax7), to neural (Sox2) and placodal (Six1) cell types 64 
(Roellig et al., 2017). This is consistent with the possibility that cells in the neural plate 65 
border are transcriptionally primed toward multiple cell fates, rather than committed to a 66 
particular lineage. What then leads to cell lineage commitment and specification toward 67 
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neural crest rather than alternative fates, and to their subsequent ability to initiate 68 
migration from the neural tube? One possibility is that previously unidentified 69 
transcriptional and epigenetic regulators play a critical role in these processes.  70 
In this study, we used scRNA-seq to identify novel transcription factors and 71 
chromatin remodelers expressed in neural crest cells of the early chick embryo. We first 72 
describe the single-cell transcriptome of early migrating neural crest cells emerging from 73 
the hindbrain, with a focus on identifying new transcriptional regulators. One of the 74 
genes uncovered in the neural crest cluster was Hmga1, a non-histone chromatin 75 
remodeler that has known roles in tumor metastasis (Resar et al., 2018), but has been 76 
understudied in development. We first characterized the expression and function of 77 
Hmga1 during neural crest development using in situ Hybridization Chain Reaction 78 
(HCR) and observed Hmga1 transcripts enriched in the neural crest, with the onset of 79 
expression preceding neural crest specification in the neural plate border. To test its 80 
functional role in neural crest development, we used plasmid- and protein-based 81 
CRISPR-Cas9 strategies to knock out Hmga1 in neural crest progenitors with temporal 82 
precision. The results demonstrate an early role for Hmga1 in neural crest lineage 83 
specification in a Pax7-dependent manner, resulting in the downregulation of neural 84 
crest specifier genes such as Snail2, FoxD3, and Sox10. Interestingly, loss of Hmga1 85 
after completion of neural crest specification revealed a distinct set of defects in cranial 86 
neural crest emigration and migration. Using in situ hybridization and a fluorescent 87 
protein-based reporter, we show that this is a consequence of reduced canonical Wnt 88 
activity mediated by Wnt1, which can be rescued by concomitantly expressing stabilized 89 
ß-catenin, thus establishing a separate role for Hmga1 in delaminating neural crest cells 90 
as a Wnt pathway activator. Taken together, these results identify a dual role for Hmga1 91 
in neural crest development with an early effect on neural crest specification and a later 92 
effect on initiation of migration via the canonical Wnt signaling pathway, mechanisms 93 
that may be inappropriately redeployed during tumorigenesis.  94 
95 
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Results  96 
 97 
Single-cell RNA-seq of early migrating hindbrain neural crest reveals novel 98 
transcriptional regulators 99 
Many RNA-seq datasets have sought to examine genes that are enriched in 100 
cranial neural crest cells compared with other tissues (Simões-Costa et al., 2014) or 101 
axial levels (Martik et al., 2019). However, here we aimed to identify highly expressed 102 
transcription factors and chromatin remodelers that may have been missed due to 103 
overlapping expression between neural crest cells and surrounding tissues. To this end, 104 
gastrula stage Hamilton Hamburger (HH) 4 embryos were electroporated with the 105 
neural crest enhancer FoxD3-NC2:eGFP and cultured ex ovo until stage HH12 106 
(Hamburger and Hamilton, 1951). The NC2 enhancer labels early migrating neural crest 107 
cells (Simões-Costa et al., 2012), thereby facilitating dissection of the region 108 
surrounding the rhombomere (r) 6 migratory neural crest stream for dissociation [Figure 109 
1A-A’]. To aid downstream analysis and clustering, we introduced an “outgroup” of 110 
dissected primary heart tube cells into the single-cell suspension and generated 111 
barcoded Gel Bead-In-Emulsions (GEMs) on the 10X Genomics platform. The library 112 
was sequenced at a depth of 50,000 median reads/cell to profile a total of 1268 cells, 113 
out of which 1241 cells passed the quality control filters [Figure 1 – figure supplement 114 
1A-C].  115 
Following mapping and dimensional reduction, the cells split into distinct cellular 116 
subtypes [Figure 1B], including five cell types (mesoderm, otic, ectoderm, hindbrain, 117 
and neural crest) derived from the dissected tissue, and the spiked-in outgroup (‘Heart 118 
tube’; Myl2+, Tnnt2+). Known genetic markers that were enriched in each population 119 
served to distinguish the neural crest subcluster (Tfap2B+, ItgB3+) from the surrounding 120 
tissues [i.e. otic placode (Cldn3+, Gbx2+); hindbrain (Pax6+, Zic2+); ectoderm (Epcam+, 121 
Crabp2+); mesoderm (FoxC2+, Col1A1+)] [Figure 1 – figure supplement 2A-B]. 122 
Consistent with the anatomical diversity of the mesoderm, the latter was further 123 
subdivided into specific cell types like myocardium (Hand2+) and paraxial mesoderm 124 
(Prrx1+) [Figure 1 – figure supplement 1D-E]. We particularly focused our subsequent 125 
analysis on the neural crest cluster in the context of the neighboring tissues of hindbrain 126 
and ectoderm [Figure 1C,D,D’].  127 
 6 
We sought to determine all transcription factors and chromatin regulators that 128 
were expressed in the neural crest-specific subcluster, regardless of their expression in 129 
other cell types. To this end, we shortlisted all genes associated with the gene ontology 130 
terms “DNA-binding”, “regulation of transcription”, and “transcription factor”. This 131 
revealed several chromatin remodelers and transcription factors with high levels of 132 
expression in neural crest cells [Figure 1E; Figure 1 – figure supplement 2C]. The 133 
identified genes fell into two groups, the first of which was comprised of transcription 134 
factors enriched in neural crest cells, with little overlap in surrounding cell types. As 135 
expected, many of these genes, including Sox10, Ets1, MafB, and Nrip1, are known for 136 
their expression in the neural crest (Gandhi et al., 2020; Tani-Matsuhana et al., 2018). 137 
Importantly, the second group was comprised of chromatin remodelers and/or 138 
transcriptional regulators previously overlooked in bulk transcriptomic datasets, 139 
including Hmga1, Dact2, Ssrp1, and Tbxl1x, due to overlapping expression in other 140 
tissues. Indeed, their distribution in low dimensional space confirmed that a high 141 
proportion of cells in the hindbrain and/or ectoderm also expressed these genes [Figure 142 
1F]. The expression of a subset of the above genes was validated at HH12 [Figure 1G-143 
K] by in situ Hybridization Chain Reaction (HCR), which revealed an abundance of 144 
transcripts in both r4 and r6 neural crest streams that emerge from the hindbrain. Taken 145 
together, the results show that our single-cell gene expression analysis is sufficient to 146 
resolve the underlying heterogeneity of the chick hindbrain. We also identified several 147 
genes expressed in migrating neural crest cells not highlighted in previous datasets 148 
given their broad expression in other tissues.  149 
 150 
Hmga1 is expressed in the neural plate, neural plate border, and neural crest cells  151 
Of the novel transcriptional regulators that were previously overlooked in bulk 152 
transcriptomic datasets, we were particularly intrigued by the chromatin remodeler 153 
Hmga1, due to its extensively studied role in tumorigenesis. A member of the High 154 
Motility Group A (HMGA) superfamily, Hmga1 encodes a small, nonhistone chromatin 155 
remodeling protein that binds to the minor groove of DNA, thereby affecting the 156 
chromatin landscape and facilitating the binding of other transcription factors in the 157 
opposing major groove (Grosschedl et al., 1994). In developing mouse embryos, 158 
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Hmga1 has been shown to have widespread expression across several tissues, 159 
including the brain, where its loss has been correlated with reduced developmental 160 
potential of neural precursor cells (Kishi et al., 2012). While well-studied in cancer 161 
(Masciullo et al., 2003; Sarhadi et al., 2006), little was known about its developmental 162 
function in neural crest cells. Given the parallels between the mechanisms that regulate 163 
delamination, migration, proliferation, and survival of neural crest cells and tumor cells 164 
(Ahsan et al., 2017), we sought to characterize the expression of Hmga1 during neural 165 
crest development.  166 
At HH12, Hmga1 was observed in migrating neural crest streams emanating 167 
from rhombomeres 4 and 6 [Figure 1K], and in the cranial mesenchyme, suggesting that 168 
its expression is not restricted to the hindbrain neural crest. Therefore, to determine its 169 
spatiotemporal pattern at early stages of neural crest development, we performed HCR 170 
for Hmga1 at stages ranging from gastrulation (HH4), when neural crest cells are 171 
undergoing induction in the neural plate border [Figure 2B’’’], to HH10, when neural 172 
crest cells have delaminated from the dorsal neural tube [Figure 2E’’’] and are mid-173 
migration in the cranial region [Figure 2F’’’]. As an early marker for the neural plate 174 
border and neural crest (Basch et al., 2006), we co-labeled Pax7 transcripts at the 175 
aforementioned stages.  176 
Hmga1 transcripts were first detected in the neural plate and neural plate border, 177 
but not in the non-neural ectoderm at HH4+, and preceded the expression of Pax7 in 178 
the neural plate border. Hmga1 expression remained high at HH5-6 [Figure 2A-B], 179 
overlapping in the neural plate border [Figure 2 – figure supplement 1A] with Pax7 180 
transcripts [Figure 2B’], as observed in transverse sections [Figure 2B”, Figure 2 – 181 
figure supplement 1B-B’]. As the neural plate border elevated to form neural folds 182 
between HH7 and HH8 [Figure 2D’’’], expression of Hmga1 was retained in the neural 183 
tube [Figure 2C-D] and continued to overlap with Pax7 in the dorsal neural folds [Figure 184 
2D’, Figure 2 – figure supplement 1C-D’]. Between stages HH9 and HH10, when neural 185 
crest cells delaminated from the dorsal neural tube [Figure 2E’’’] and started migrating 186 
laterally [Figure 2F’’’], Hmga1 expression was retained in delaminating [Figure 2E,E’,E’’, 187 
Figure 2 – figure supplement 1E-F’] and migrating [Figure 2F,F’,F’’, Figure 2 – figure 188 
supplement 1G-H’] neural crest cells. Interestingly, transverse sections through a 189 
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representative HH10 embryo revealed that within the migrating neural crest stream, 190 
Hmga1 was expressed in both leader and follower cells, as compared to Pax7, which 191 
appeared to be downregulated in the leader cells [Figure 2F’’]. Together, these results 192 
show that the onset of Hmga1 in the neural crest occurs in precursors at the neural 193 
plate border region prior to their specification, and is retained in premigratory and 194 
migrating neural crest cells. 195 
 196 
Hmga1 is necessary for neural crest specification 197 
Given that Hmga1 transcripts were enriched in the cranial neural crest, we 198 
sought to interrogate its possible role therein. To this end, we designed guide RNA 199 
plasmids (gRNAs) targeting the coding sequence of Hmga1 [Figure 3 – figure 200 
supplement 1A] and electroporated them together with constructs encoding Cas9 and 201 
nuclear RFP on the right side of HH4 gastrula stage embryos [Figure 3A]. The left side 202 
of the embryo was electroporated with Cas9, nuclear RFP, and a control gRNA, chosen 203 
for its lack of binding in chick cells (Gandhi et al., 2017). Embryos were cultured ex ovo 204 
until stage HH9/9+ [Figure 3B], after which they were processed for 205 
immunohistochemistry, in situ hybridization, and HCR.  206 
We first validated our knockout approach by probing for the expression of Hmga1 207 
itself in knockout embryos using HCR. This revealed a significant reduction in the 208 
abundance of Hmga1 transcripts on the knockout side [Figure 3C]. We quantified this 209 
phenotype in whole-mount embryos and observed a 25% reduction in Hmga1 210 
expression [Figure 3D, Figure 3 – source data 1; p < 0.05, Wilcoxon rank test]. Notably, 211 
the loss of Hmga1 transcripts in the neural crest was more dramatic than in the neural 212 
tube, due to targeted electroporation of knockout reagents to the presumptive neural 213 
plate border region. Next, we investigated the effect of knocking out Hmga1 on Pax7 214 
expression in neural crest cells. We examined Pax7 mRNA expression by HCR in 215 
embryos where Hmga1 was knocked out on the right side, relative to the left side which 216 
served as an internal control. Consistent with their hierarchical onset of expression, loss 217 
of Hmga1 resulted in a notable reduction in Pax7 mRNA levels [Figure 3E]. Next, we 218 
assessed whether the reduction in Pax7 transcripts would consequently result in a loss 219 
of Pax7 protein in the neural crest by immunostaining Hmga1-knockout embryos with a 220 
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Pax7 antibody. As expected, Pax7 protein levels were dramatically reduced in the 221 
migratory cranial neural crest [Figure 3F,H’], with further analysis revealing a significant 222 
decrease in the number of Pax7+ cells on the knockout side compared to the control 223 
side [Figure 3G, Figure 3 – source data 2; p < 0.0001, student’s t-test]. Moreover, in the 224 
absence of Hmga1, cranial neural crest cells failed to migrate properly, as depicted by 225 
the expression of the migratory neural crest marker HNK1 [Figure 3 – figure supplement 226 
1B]. A transverse section through the hindbrain [Figure 3H] of another representative 227 
Hmga1-knockout embryo stained for Pax7 [Figure 3H’] revealed a notable reduction in 228 
the expression of Pax7 [Figure 3I] as well as the neural crest specifier Snail2 on the 229 
knockout side [Figure 3I’]. Furthermore, using in situ hybridization, we found that other 230 
neural crest specifier genes including FoxD3 [Figure 3J,J’, Figure 3 – figure supplement 231 
1D,E’,E’’], Tfap2b [Figure 3K], Sox10 [Figure 3L,L’], and c-Myc [Figure 3 – figure 232 
supplement 1C] were also downregulated on the knockout side. In transverse sections 233 
through Hmga1-knockout embryos labeled for Sox10 expression [Figure 3L], we also 234 
detected fewer Pax7+ cells [Figure 3N] and diminished levels of HNK1 expression 235 
[Figure 3M]. On the other hand, no notable difference in the thickness of the neural tube 236 
was observed [Figure 3H,J’,M’’, Figure 3 – figure supplement 1E], suggesting that the 237 
targeted knockout of Hmga1 in the neural plate border affected the neural folds/dorsal 238 
neural tube but not the neural plate itself. Taken together, our results indicate that 239 
Hmga1 is important for proper specification of neural crest cells. 240 
 241 
Hmga1 regulates expression of Pax7 in neural crest precursors in the neural plate 242 
border 243 
 As the expression of Hmga1 precedes that of Pax7 in the neural plate border, 244 
and its loss also causes a reduction of Pax7 levels in neural crest cells [Figure 3F], we 245 
next asked if this regulation occurs in the neural crest precursors that reside in the 246 
neural plate border. In the preceding experiments, we characterized the expression of 247 
neural crest markers following CRISPR-plasmid-mediated loss of Hmga1 at stages 248 
corresponding to early stages of neural crest emigration and migration. However, one 249 
caveat to our plasmid knockout strategy is that it takes time after electroporation of the 250 
CRISPR constructs in gastrula stage embryos for Cas9 to transcribe, translate, and 251 
 10 
properly fold to form a functional Cas9-gRNA complex. As specification of neural crest 252 
cells at the neural plate border is ongoing at HH4, this means that functional Cas9 253 
would not be available until well after initial electroporation. Given that neural crest 254 
development occurs in a rostral-to-caudal wave along the body axis (Gandhi and 255 
Bronner, 2018), we speculated that effects of plasmid electroporation would be more 256 
penetrant in the hindbrain compared to anterior regions of the embryo, such as the 257 
midbrain. To test this possibility, we generated transverse sections through the midbrain 258 
[Figure 4A] and hindbrain [Figure 4B] of Hmga1-knockout embryos and quantified the 259 
number of Pax7+ cells as a ratio of cell count on the experimental versus control sides. 260 
Accordingly, we noticed that while this ratio was 0.948±0.036 (n=5) at the midbrain 261 
level, it was significantly reduced in the dorsal hindbrain, with a mean ratio of 0.69±0.08 262 
(n=5; p<0.05, paired Student’s t-test) [Figure 4C, Figure 4 – source data 1]. These 263 
results supported our assumption that specification may have already occurred at the 264 
midbrain level by the time Cas9 was functionally active.  265 
To circumvent this issue and test the earliest effects of knocking out Hmga1 266 
concomitant with its onset of expression, we turned to an alternative CRISPR knockout 267 
strategy that enabled the loss of Hmga1 immediately after transfection. To this end, we 268 
electroporated recombinant Cas9 protein with in vitro-transcribed Hmga1 or control 269 
gRNA as ribonucleoprotein (RNP) complexes on the right and left sides of gastrula 270 
stage embryos, respectively [Figure 4D], and cultured embryos ex ovo until HH6. First, 271 
to validate the Cas9-protein-mediated knockout strategy, we labeled Hmga1 transcripts 272 
in knockout embryos using HCR and observed a very efficient reduction in Hmga1 273 
expression [Figure 4E], especially in the neural plate border, thereby offering precise 274 
temporal control over the loss of this gene’s activity. Next, we assayed for the 275 
expression of Pax7 in the neural plate border by immunostaining Hmga1-knockout 276 
embryos and found that the levels of Pax7 protein in the neural plate border [Figure 4F, 277 
Figure 4 – figure supplement 1A] were severely downregulated. Transverse sections 278 
through the experimental compared with control sides revealed that neural plate border 279 
cells no longer expressed Pax7 after the loss of Hmga1 [Figure 4H,I], and that this was 280 
not a result of premature apoptosis or aberrant cell proliferation [Figure 4 – figure 281 
supplement 1B-G’, Figure 4 – figure supplement 1 – source data 1]. In further support of 282 
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the latter, the thickness of the neural plate border remained unchanged [Figure 4H’,I’]. 283 
We also quantified the corrected Pax7 total fluorescence intensity (C.T.C.F) in the 284 
neural plate border and observed a statistically significant difference between the 285 
control and knockout sides (p<0.01, paired student’s t-test), with mean Pax7 intensity on 286 
the control side being 89.853±23.388 a.u. (n=5) as compared to 42.763±16.079 a.u. 287 
(n=5) on the knockout side [Figure 4J, Figure 4 – figure supplement 1H, Figure 4 – 288 
source data 2]. Taken together, these results suggest that Hmga1 is required for the 289 
expression of Pax7 in neural crest precursors that are induced in the neural plate 290 
border.  291 
 292 
Hmga1 is not required for expression of neural plate border genes Msx1 or 293 
Tfap2a  294 
The neural plate border was initially thought to contain discrete domains 295 
corresponding to neural, neural crest, placodal, and epidermal precursors. However, 296 
recent work has demonstrated that cells in this region co-express genes characteristic 297 
of different cell fates and exhibit a broad developmental potential, suggesting they are 298 
not restricted to individual cell fates until later in development (Roellig et al., 2017). In 299 
chick embryos, Tfap2a and Msx1 are expressed in the neural plate border, with Tfap2a 300 
transcripts spanning both the neural plate border and the non-neural ectoderm (De 301 
Crozé et al., 2011; Luo et al., 2003), whereas Msx1 transcripts are expressed within a 302 
subset of Pax7+ cells in the neural plate border region (Khudyakov and Bronner-Fraser, 303 
2009). Given that loss of Hmga1 resulted in a reduction in Pax7 protein levels in the 304 
neural plate border, we asked if this was a result of a general neural plate border defect 305 
versus a selective effect on Pax7. To test this, we examined the expression of Tfap2a 306 
[Figure 4K] and Msx1 [Figure 4N] transcripts together with Pax7 using HCR in Hmga1-307 
knockout embryos developed to neurula stages. Consistent with the loss of Pax7 308 
protein in the neural plate border, Hmga1 knockout caused reduced Pax7 mRNA levels 309 
on the experimental [Figure 4M,P] compared to the control [Figure 4L,O] sides. 310 
However, the expression of Tfap2a [Figure 4L’,M’] and Msx1 [Figure 4O’,P’] was 311 
retained in the absence of Hmga1, together with no noticeable difference in the 312 
thickness of the neural plate border [Figure 4L’’,M’’,O’’,P’’]. Since Pax7 and Msx1 are 313 
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specifically expressed in the neural plate border, we quantified the corrected total cell 314 
fluorescence intensity per unit area associated with their transcripts and calculated the 315 
ratio between the experimental and control sides. Under control conditions, this ratio 316 
would be close to 1. However, for Pax7, the mean calculated ratio was 0.552±0.06 317 
(n=6), with a statistically significant difference between the experimental and control 318 
sides (p<0.001, paired Student’s t-test). On the other hand, while the mean calculated 319 
ratio for Msx1 was 0.809±0.098 (n=3), the fluorescence intensities were not significantly 320 
different between the two sides [Figure 4Q, Figure 4 – source data 3]. Taken together, 321 
these results show that Hmga1 specifically regulates Pax7 expression at the neural 322 
plate border. 323 
 324 
Hmga1 and Pax7 rescue the effects of losing Hmga1 on neural crest specification  325 
Given that loss of Hmga1 affects neural crest specification, we asked if its 326 
overexpression would have the converse effect. To exogenously provide Hmga1, we 327 
designed a plasmid construct containing the coding sequence of Hmga1 under the 328 
regulation of a ubiquitous enhancer/promoter combination [Figure 5A]. This construct 329 
also contained the coding sequence for nuclear RFP downstream of an Internal 330 
Ribosome Entry Site (IRES), allowing identification of successfully transfected cells. To 331 
test the effect of overexpressing Hmga1, we electroporated this construct on the right 332 
side of gastrula stage embryos and cultured them ex ovo until HH9+. The left side 333 
served as an internal control and was electroporated with an equal concentration of a 334 
construct encoding nuclear RFP alone [Figure 5B]. The results show that, rather than 335 
having the opposite effect to loss of function, overexpression of Hmga1 also resulted in 336 
a notable reduction in Pax7 expression on the experimental side [Figure 5C]. This 337 
suggests that maintaining appropriate levels of Hmga1 is critical for proper neural crest 338 
specification.  339 
The gold standard to demonstrate specificity for loss-of-function experiments is to 340 
perform a rescue. We posited that if modulating the levels of Hmga1 was important for 341 
neural crest formation, then exogenous expression of Hmga1 in an Hmga1-knockout 342 
background should successfully rescue neural crest cell numbers. Since the 343 
Protospacer Adjacent Motifs (PAMs) adjacent to both Hmga1 gRNAs are located in the 344 
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introns [Figure 3 – figure supplement 1A], the coding sequence on the plasmid would be 345 
guarded against the endonuclease activity of Cas9. To test our hypothesis, we knocked 346 
out Hmga1 using CRISPR plasmids as described above, but co-electroporated the 347 
“rescue” construct on the right side. The left side was electroporated with an equal 348 
concentration of a plasmid encoding nuclear RFP. Embryos cultured to HH9+ and 349 
immunostained for Pax7 revealed that overexpression of Hmga1 concomitant with 350 
knocking out the endogenous gene successfully rescued Pax7 levels in cranial neural 351 
crest cells [Figure 5D]. To quantify the extent of rescue, we calculated the ratio of the 352 
number of Pax7+ cells on the experimental versus control sides in both wholemount 353 
“knockout” [from Figure 3G] and “rescue” embryos [Figure 5D]. In unperturbed embryos, 354 
this ratio will be close to 1, reflecting similar numbers of Pax7+ cells on both sides of the 355 
embryo. However, in the “knockout” group, we observed a mean ratio of 0.767±0.041 356 
(n=11), which was significantly different from the ratio of 0.946±0.016 (n=8) observed in 357 
the “rescue” group (p<0.001, Welch two-sample t-test) [Figure 5E, Figure 5 – source 358 
data 1]. Next, we probed for the expression of the neural crest specifier gene Sox10 to 359 
ask if rescuing the expression of Hmga1 truly restored the process of neural crest 360 
specification. To do this, we processed “rescue” embryos for HCR against Sox10 361 
[Figure 5F] together with Pax7 [Figure 5G]. Indeed, restoring the levels of Hmga1 was 362 
sufficient to rescue the expression of Sox10 [Figure 5G’] and Pax7 [Figure 5G’’] in early 363 
migrating crest, and Pax7 in the premigratory crest residing in the dorsal neural tube, as 364 
visualized in transverse sections through the embryo. We also confirmed that the 365 
expression of the “rescue” construct was restricted to the dorsal neural tube [Figure 366 
5G’’’], thereby precluding unintended effects on neural tube development.  367 
Finally, given that the loss of Hmga1 specifically affected Pax7 expression in 368 
neural crest precursors, we asked if exogenous expression of Pax7 would be sufficient 369 
to rescue the effects of losing Hmga1 on neural crest specification. We tested this by 370 
overexpressing the coding sequence of Pax7 (Roellig et al., 2017) on the right side of 371 
gastrula stage embryos together with CRISPR plasmids targeting Hmga1 [Figure 372 
5H,H’]. Given that the effect of CRISPR-plasmid-mediated loss of Hmga1 was more 373 
penetrant posteriorly, we developed “Pax7-rescue” embryos to HH9+, processed them 374 
for HCR against the neural crest specifier genes Tfap2b [Figure 5I] and Snai2 [Figure 375 
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5I’], and generated transverse sections through the hindbrain. Tfap2b is expressed in 376 
delaminating and migrating neural crest cells (Simoes-Costa and Bronner, 2016), 377 
whereas Snai2 is expressed in premigratory neural crest and is eventually 378 
downregulated as the cells begin to migrate (Taneyhill et al., 2007). Compared to the 379 
Hmga1-knockout embryos in which Tfap2b mRNA [Figure 3K] and Snail2 protein 380 
[Figure 3I’] levels were notably downregulated, restoring the levels of Pax7 in an Hmga1 381 
knockout background rescued the expression of both Tfap2b [Figure 5J] and Snai2 382 
[Figure 5K] in the dorsal hindbrain. Together, these results suggest that maintaining the 383 
correct levels of Hmga1 is necessary for proper neural crest specification in a Pax7-384 
dependent manner.  385 
 386 
Hmga1 activates Wnt signaling to mediate neural crest emigration 387 
 Neural crest induction, specification, and emigration from the neural tube are 388 
intricate processes that require an interplay between Wnt, FGF, and BMP signaling 389 
pathways (Piacentino and Bronner, 2018; Woda et al., 2003) working reiteratively at 390 
different stages of development. For example, at the onset of neural crest emigration, 391 
Wnt1 is prominently expressed in the dorsal neural tube, where premigratory neural 392 
crest cells reside (Simões-Costa et al., 2015). As a result, these cells turn on Snai2, a 393 
critical regulator of EMT (Nieto et al., 1994) known to function downstream of the Wnt 394 
signaling pathway.  395 
After knocking out Hmga1 using CRISPR plasmids, we noted not only perturbed 396 
emigration but also a dramatic reduction in Snail2 levels, even within the subset of 397 
Pax7-expressing cells in the dorsal neural folds [Figure 3I’]. These results raised the 398 
intriguing possibility that this might be due to an effect on Wnt signaling in already-399 
specified premigratory neural crest cells. Accordingly, we hypothesized that Hmga1 may 400 
function as a Wnt activator in these cells. If so, its loss would be predicted to result in 401 
reduced Wnt signaling in the dorsal neural tube. To test this possibility, we used a 402 
reporter construct expressing nuclear GFP under the regulation of six Tcf/Lef binding 403 
sites and a minimal promoter as a readout for canonical Wnt signaling (Ferrer-Vaquer et 404 
al., 2010) [Figure 6A]. Plasmids encoding Cas9, gRNAs targeting Hmga1, nuclear RFP, 405 
and Tcf/Lef:H2B-GFP were electroporated on the right side of gastrula stage embryos, 406 
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while the left control side was electroporated with plasmids encoding Cas9, control 407 
gRNA, nuclear RFP, and Tcf/Lef:H2B-GFP. As described above, this plasmid-based 408 
knockout strategy resulted in the loss of Hmga1 after neural crest specification in the 409 
midbrain but well before their emigration. Embryos were allowed to develop until HH9, 410 
by which time neural crest cells have started delaminating from the neural tube at the 411 
midbrain level [Figure 6B]. Consistent with our hypothesis, the results show that Hmga1 412 
knockout caused a notable reduction in canonical Wnt reporter activity on the knockout 413 
side compared to the control side [Figure 6C] at the midbrain level. Interestingly, these 414 
embryos had a neural crest migration defect [Figure 6 – figure supplement 1C-D] but no 415 
notable difference in the number of Pax7+ cells between the two sides [Figure 6 – figure 416 
supplement 1E’], as expected if the Hmga1 knockout occurred after specification was 417 
complete; this is consistent with previous work showing that perturbation of canonical 418 
Wnt signaling following specification does not affect the number of Pax7+ cells at cranial 419 
EMT stages (Hutchins and Bronner, 2018). Quantitation of this effect revealed a 420 
significant reduction in reporter activity following the loss of Hmga1 [Figure 6D, Figure 6 421 
– source data 1; p < 0.01; student’s t-test], as measured by comparing the ratio between 422 
the knockout and the control sides of transfected cells (RFP+) that turned on Wnt 423 
signaling within the Pax7+ domain, therefore expressing GFP. While this ratio was 424 
expected to be 1 for embryos with unperturbed Wnt signaling on both sides, we 425 
observed a mean ratio of 0.325±0.082 (n=5), suggesting that Wnt activity was disrupted 426 
in the absence of Hmga1.  427 
Next, to investigate the mechanism by which Hmga1 regulates Wnt signaling, we 428 
turned to a recently published cranial neural crest chromatin accessibility dataset 429 
(Williams et al., 2019) and looked for open chromatin regions surrounding genes that 430 
encode for known Wnt ligands. In particular, Wnt1 expression in the dorsal neural tube 431 
is known to be necessary for proper delamination of cranial neural crest cells (Simões-432 
Costa et al., 2015). Interestingly, we discovered a putative enhancer downstream of 433 
Wnt1 [Figure 6 – figure supplement 1A] that contained an AT-rich domain consistent 434 
with Hmga1 binding motifs [Figure 6 – figure supplement 1B] (Reeves and Nissen, 435 
1990). Therefore, we hypothesized that Hmga1 may modulate Wnt signaling by 436 
regulating Wnt1 expression. To test this, we knocked out Hmga1 on the right side of 437 
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gastrula stage embryos using CRISPR plasmids, cultured them ex ovo until HH9, and 438 
examined Wnt1 mRNA expression using in situ hybridization. Indeed, the dorsal neural 439 
tube expression of Wnt1 was severely downregulated [Figure 6E] in the midbrain. 440 
Consistent with the effect of losing Hmga1 after neural crest specification, the number of 441 
Pax7+ cells in the dorsal neural tube appeared unchanged [Figure 6E’]. In contrast, no 442 
change in Wnt1 expression was observed at the hindbrain level [Figure 6F] which, being 443 
developmentally “younger,” instead exhibited a specification defect that resulted in 444 
fewer Pax7+ cells in the dorsal neural tube on the experimental side compared to the 445 
control side [Figure 6F’]. Interestingly, following Hmga1 knockout, we also observed 446 
defects in basement membrane remodeling and laminin channel formation at midbrain 447 
levels [Figure 6G], another Wnt-dependent process necessary for neural crest EMT; 448 
consistent with Wnt inhibition via Draxin overexpression (Hutchins and Bronner, 2019), 449 
loss of Hmga1 abrogated laminin remodeling and resulted in physical blockage of the 450 
channel through which migrating cranial neural crest cells normally transit [Figure 6H]. 451 
Together, these data indicate that after neural crest specification, Hmga1 is necessary 452 
for the expression of Wnt1 and activation of canonical Wnt signaling in the dorsal neural 453 
tube, and by extension, Wnt-dependent neural crest delamination/EMT. 454 
Finally, given that Hmga1 functions as a canonical Wnt pathway activator, we 455 
asked if the migration defects caused by the loss of Hmga1 post-specification can be 456 
rescued by restoring canonical Wnt signaling in premigratory neural crest cells. To 457 
address this, we expressed GFP-tagged, stabilized ß-catenin (NC1-∆90 ß-cat) to 458 
upregulate canonical Wnt signaling output specifically in premigratory neural crest cells, 459 
thus circumventing the critical process of neural crest induction at the neural plate 460 
border (Hutchins and Bronner, 2018). If loss of Hmga1 in premigratory neural crest cells 461 
resulted in migration defects due to reduced canonical Wnt signaling, expression of a 462 
stabilized ß-catenin would be predicted to restore those levels, thereby rescuing proper 463 
migration. To test this, we knocked out Hmga1 on the right side of gastrula stage 464 
embryos using CRISPR plasmids as previously described, but co-electroporated NC1-465 
∆90ß-cat-GFP on the right side. The left side was electroporated with control reagents 466 
[Figure 6I]. Embryos were cultured ex ovo until HH9+ and processed for 467 
immunohistochemistry against Pax7. Consistent with our hypothesis that Hmga1 468 
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functions as a Wnt activator in neural crest cells, expression of stabilized ß-catenin was 469 
sufficient to rescue proper cranial neural crest migration from Hmga1 knockdown 470 
[Figure 6J]. We also calculated the ratio of the area occupied by migrating cranial neural 471 
crest cells between the experimental and control sides [Figure 6K, Figure 6 – source 472 
data 2]. For wildtype embryos, this ratio would be close to 1, reflecting equal neural 473 
crest migration on both sides of the embryo. However, after the loss of Hmga1, the ratio 474 
of areas on experimental versus control sides was 0.642±0.028 (n=5). Importantly, co-475 
expression of stabilized ß-catenin in premigratory neural crest rescued migration, with 476 
an average migration ratio of 1.015±0.035 (n=4), which was significantly different from 477 
the knockout group (p<0.0001, ANOVA and post hoc Tukey HSD). Similarly, ubiquitous 478 
expression of the Hmga1 coding sequence also rescued neural crest migration, with an 479 
average migration ratio of 0.972±0.044 (n=5), which was also significantly different from 480 
the knockout group (p<0.001, ANOVA and post hoc Tukey HSD). Taken together, our 481 
results suggest that Hmga1 mediates the process of EMT by activating canonical Wnt 482 
signaling in premigratory neural crest cells, thus enabling them to emigrate from the 483 
neural tube. 484 
  485 
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Discussion 486 
While chromatin modifiers are known to influence gene expression and cell fate 487 
decisions at many stages of development (Caia et al., 2014; Laugesen and Helin, 2014; 488 
Miller and Hendrich, 2018; O’Shaughnessy-Kirwan et al., 2015), parsing cell-type-489 
specific functions and targets for these proteins is often challenging due to broad 490 
expression across multiple tissues and time points. In this study, we have used scRNA-491 
seq to identify a chromatin-remodeling protein, Hmga1, as highly expressed in neural 492 
crest cells. Using high resolution in situ HCR and temporally controlled knockdowns, we 493 
present evidence for a dual role of Hmga1 in the formation and migration of neural crest 494 
cells. At early stages, we find that the neural plate border gene Pax7 is a downstream 495 
target of Hmga1, such that loss of Hmga1 blocks neural crest specification in a manner 496 
that can be rescued by restoring Pax7 expression. After neural crest specification is 497 
complete in the closing neural tube, Hmga1 plays a second role in modulating canonical 498 
Wnt signaling via alterations in the levels of Wnt1 in premigratory neural crest cells. This 499 
in turn influences neural crest EMT and delamination from the dorsal neural tube [Figure 500 
7].  501 
The canonical Wnt signaling pathway is a major input in a complex GRN that 502 
activates transcriptional circuits and controls neural crest specification and cell lineage 503 
decisions (Martik and Bronner, 2017; Simões-Costa and Bronner, 2015; Williams et al., 504 
2019), influencing multiple aspects of neural crest development from induction at the 505 
neural plate border to proliferation, onset of migration via EMT, and differentiation (Milet 506 
and Monsoro-Burq, 2012; Rabadán et al., 2016; Simões-Costa and Bronner, 2015; 507 
Steventon et al., 2009; Wu et al., 2003; Yanfeng et al., 2003). For example, regulation 508 
of the levels of canonical Wnt signaling is critical for progressive basement membrane 509 
remodeling during neural tube closure and neural crest delamination. Consequently, 510 
perturbation of Wnt signaling output at different stages of basement membrane 511 
remodeling or delamination causes severe defects in neural crest EMT (Hutchins and 512 
Bronner, 2019; Rabadán et al., 2016). Interestingly, early inhibition of canonical Wnt 513 
signaling in gastrula stage chick embryos has been shown to reduce Pax7 expression 514 
(Basch et al., 2006), whereas canonical Wnt inhibition after neural crest specification 515 
does not alter Pax7 expression but has a marked effect on EMT (Hutchins and Bronner, 516 
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2018). This suggests that there are separable early versus late effects of canonical Wnt 517 
signaling during neural crest development. 518 
Hmga1 has been shown to upregulate canonical Wnt signaling components and 519 
downstream targets in the intestinal stem cell niche, thereby amplifying signaling output 520 
(Xian et al., 2017) presumably through increased promotor accessibility. Our results are 521 
consistent with a similar role for Hmga1 in the neural crest, where its loss resulted in 522 
decreased output from a canonical Wnt reporter [Figure 6] as well as downregulation of 523 
the Wnt1 ligand [Figure 6] and the canonical Wnt target Snail2 [Figure 3]. However, 524 
temporally controlled knockdowns revealed that loss of Hmga1 reduced Wnt1 525 
expression following completion of neural crest specification, but not at earlier stages of 526 
neural crest induction. Conversely, Hmga1 knockdown affected Pax7 expression during 527 
neural crest induction but not after specification is complete. One possible explanation 528 
is that once open/remodeled, the chromatin landscape surrounding the Pax7 regulatory 529 
regions form topologically-associating domains (TADs) that are stable and resistant to 530 
repression. Alternatively, other Hmga1-independent cis-elements may influence Pax7 531 
expression following neural crest induction. Given that neural crest cells appear to have 532 
highly dynamic chromatin accessibility surrounding spatiotemporally-regulated enhancer 533 
elements (Williams et al., 2019), we would predict the latter, though further investigation 534 
is needed to distinguish between these possibilities. 535 
An intriguing possibility is that Hmga1, in addition to regulating neural crest EMT, 536 
is necessary for maintaining the broad developmental potential of neural crest cells. 537 
Neural crest cells exhibit stem-cell-like properties, including multipotency and self-538 
renewal. Thus, the early expression of Hmga1 in neural crest precursors, together with 539 
its reported role in maintaining stemness and self-renewal properties in various stem 540 
cell and cancer systems (Battista et al., 2003; Schuldenfrei et al., 2011; Shah and 541 
Resar, 2012), may indicate a role in maintaining neural crest stemness. In the dorsal 542 
neural tube, self-renewal within the premigratory neural crest is driven by the 543 
transcription factor c-Myc (Kerosuo and Bronner, 2016), which together with its binding 544 
partner regulates cell cycle progression. Consistent with this possibility, we found that 545 
the mRNA expression of c-Myc is downregulated in the dorsal neural tube following 546 
Hmga1 knockout. However, given that canonical Wnt signaling also regulates stem cell 547 
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self-renewal (Xu et al., 2016), as well as cell cycle progression in neural crest (Burstyn-548 
Cohen et al., 2004), Hmga1 may have additional Wnt-dependent and/or Wnt-549 
independent roles in the maintenance of the neural crest stem cell pool. 550 
Hmga1 is a member of the high motility group A (HMGA) family of genes that are 551 
characterized by their A/T-hook domains and the ability to transform chromatin 552 
architecture to regulate transcription of target genes. To date, two members of the 553 
HMGA family, Hmga1 and Hmga2, have been identified in mammals (Reeves et al., 554 
2001), each having distinct roles in oncogenesis (Jun et al., 2015; Meyer et al., 2007; 555 
Miyazawa et al., 2004). As both genes share several common targets, they may 556 
compensate for each other where they overlap. Indeed, Hmga1/Hmga2 double 557 
knockout mice have severe embryonic lethality, compared to less-penetrant effects in 558 
individual knockouts (Federico et al., 2014). While both Hmga1 and Hmga2 genes are 559 
annotated in the chick genome, our scRNA-seq results show that a significant 560 
proportion of neural crest cells express Hmga1 but not Hmga2. Consistent with this, 561 
loss of Hmga1 resulted in neural crest-related developmental defects, making it unlikely 562 
that there is redundancy and/or compensation by Hmga2 in chick embryos. 563 
Interestingly, only the hmga2 paralogue is present in Xenopus laevis embryos (Macrì et 564 
al., 2016), but morpholino-mediated knockdown of hmga2 did not affect the expression 565 
of neural plate border gene pax3/7. This contrasts with our results in chick embryos, 566 
where the loss of Hmga1 affected both Pax7 transcription and protein levels in the 567 
neural plate border. Together with the absence of Hmga2+ cells in our single-cell data, 568 
this raises the possibility that individual HMGA family members play discrete roles in 569 
neural crest development, similar to their distinct roles in tumorigenesis.  570 
In addition to Hmga1, other chromatin remodeling proteins serve similar functions 571 
in neural crest cell fate decisions. For example, both the ATP-dependent chromatin 572 
remodeler CHD7 and the histone demethylase Jumonji D2A (KDM4A/JmjD2A) are 573 
necessary for expression of neural crest specifier genes; notably, however, these 574 
chromatin modifiers appear to function at later developmental time points than Hmga1, 575 
as neither knockdown of KDM4A in chick embryos nor CHD7 in Xenopus embryos 576 
affect Pax3/7 expression levels (Bajpai et al., 2010; Strobl-Mazzulla et al., 2010). 577 
Furthermore, KDM4A influences Snai2 and Wnt1 levels, raising the possibility that 578 
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Hmga1 may act in concert with KDM4A or other chromatin remodelers to restructure the 579 
accessibility of neural crest GRN circuits at different cell fate checkpoints.  580 
In summary, our data reveal a dual role for the chromatin remodeler Hmga1 581 
during neural crest development. First, during specification at the neural plate border, 582 
Hmga1 regulates the completion of neural crest induction as assayed by readout of 583 
Pax7 expression at the neural plate border. Later, following neural crest specification, 584 
Hmga1 plays a second role in modulating the levels of the canonical Wnt signaling 585 
pathway in the closing dorsal neural tube to influence neural crest EMT and 586 
delamination at the onset of their migration. Post-embryonically, neural-crest-derived 587 
cells are prone to metastasis and give rise to numerous cancers (Maguire et al., 2015). 588 
Furthermore, neural crest and cancer cells often employ similar mechanisms to drive 589 
EMT; in particular, the hallmarks of metastasis often involve disruption of the basement 590 
membrane which may also be driven by canonical Wnt signaling (Ahsan et al., 2017; 591 
Powell et al., 2013). Interestingly, high expression levels of Hmga1 have been 592 
associated with premature EMT and prolonged stemness in several cancers of the 593 
pancreas (Abe et al., 2000), breast (Flohr et al., 2003), lung (Sarhadi et al., 2006), and 594 
ovaries (Masciullo et al., 2003). Therefore, it is interesting to note that Hmga1 may play 595 
parallel roles in neural crest development and cancer metastasis. Understanding how 596 
Hmga1, and chromatin remodeling in general, alters cell fate decisions and EMT 597 
through signaling and transcriptional regulation in neural crest cells will undoubtedly 598 
have important and broad implications in human development and disease. 599 
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Materials and Methods 617 
Key Resources Table 
Reagent 
type 
(species) or 
resource 
Designatio
n 
Source or 
reference Identifiers Additional information 
gene (Gallus 
gallus) Hmga1 
UCSC 
genome 
browser 
NM_204369.1 
 
strain, strain 
background 
(Gallus 
gallus) 
G. gallus 
Sun State 
Ranch 
(Monrovia, 
CA, USA) 
  
antibody 
Mouse 
IgG1 anti-
Pax7 
Developm
ental 
Studies 
Hybridoma 
Bank 
RRID: 
AB_528428 1:10 
antibody Rabbit anti-Laminin 
Sigma-
Aldrich 
RRID: 
AB_477163 1:1000 on sections 
antibody Mouse IgM 
anti-HNK1 
Developm
ental 
Studies 
Hybridoma 
Bank 
RRID: 
AB_2314644 
 
1:5 
antibody Rabbit anti-RFP MBL 
RRID: 
AB_591279 1:500 
antibody 
Rabbit anti-
Slug 
(C19G7) 
Cell 
Signaling 
RRID: 
AB_2239535 1:200 
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antibody Goat IgG 
anti-GFP Rockland 
RRID: 
AB_218182 1:500 
antibody 
Rabbit anti-
cleaved-
caspase-3 
R&D 
systems 
RRID: 
AB_2243952 1:500 on sections 
antibody 
Mouse anti-
phospho-
histone H3 
Abcam RRID: AB_443110 1:500 on sections 
recombinant 
DNA reagent 
pCI-H2B-
RFP 
(plasmid) 
Betancur 
et al., 
2010   
recombinant 
DNA reagent 
CAG>nls-
Cas9-nls 
(plasmid) 
Gandhi et 
al., 2017 
RRID: 
Addgene_99138  
recombinant 
DNA reagent 
cU6.3> Ctrl. 
gRNA.f+e 
(plasmid) 
Gandhi et 
al., 2017 
RRID: 
Addgene_99140  
recombinant 
DNA reagent 
cU6.3> 
Hmga1.1. 
gRNA.f+e 
(plasmid) 
This paper 
 
Detailed in Materials and 
Methods section “CRISPR-
Cas9-mediated 
perturbations” 
recombinant 
DNA reagent 
cU6.3> 
Hmga1.2. 
gRNA.f+e 
(plasmid) 
This paper 
 
Detailed in Materials and 
Methods section “CRISPR-
Cas9-mediated 
perturbations” 
recombinant 
DNA reagent 
FoxD3-
NC2:eGFP 
(plasmid) 
Simões-
Costa et 
al., 2012   
recombinant 
DNA reagent 
Tcf/Lef: 
H2B-GFP 
(plasmid) 
Ferrer-
Vaquer et 
al., 2010 
RRID: 
Addgene_32610  
recombinant 
DNA reagent 
NC1-∆90β-
cat 
(plasmid) 
Hutchins 
and 
Bronner,   
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2018 
recombinant 
DNA reagent 
pCI-Pax7-
IRES-H2B-
RFP 
(plasmid) 
Roellig et 
al., 2017   
sequence-
based 
reagent 
Hmga1.1. 
gRNA This paper PCR primer 
5’-
gCAGGAAGAAACCGGAGg
ta 
sequence-
based 
reagent 
Hmga1.2. 
gRNA This paper PCR primer 
5’-
GCCAGCTCCAAAGGCAG
Ggt 
sequence-
based 
reagent 
AscI-V5-
Fwd This paper PCR primer 
5’-
ggcgcgccaccATGGCTGGT
AAGCCTA 
sequence-
based 
reagent 
V5-Hmga1-
Fwd This paper PCR primer 
5’-
CTCCTCGGTCTCGATTCT
agcgacgccggcgccaagcc 
sequence-
based 
reagent 
Hmga1OLP
-V5-Rev This paper PCR primer 
5’-
ggcttggcgccggcgtcgctAGAA
TCGAGACCGAGGAG 
sequence-
based 
reagent 
Hmga1-
ClaI-Rev This paper PCR primer 
5’-
ttatcgattcactgctcctcctcggatg 
sequence-
based 
reagent 
Hmga1.1 
short guide 
oligo 
This paper PCR primer 
5’-
GCGTAATACGACTCACTA
TAGGCAGGAAGAAACCG
GAGGTAGTTTTAGAGCTA
GAAATAGC 
sequence-
based 
reagent 
Hmga1.2 
short guide 
oligo 
This paper PCR primer 
5’-
GCGTAATACGACTCACTA
TAGGCCAGCTCCAAAGG
CAGGGTGTTTTAGAGCTA
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GAAATAGC 
sequence-
based 
reagent 
Control 
short guide 
oligo 
Hutchins 
and 
Bronner, 
2018 
PCR primer 
Detailed in Materials and 
Methods section “CRISPR-
Cas9-mediated 
perturbations” 
sequence-
based 
reagent 
gRNA 
Primer 1 
Hutchins 
and 
Bronner, 
2018 
PCR primer 
Detailed in Materials and 
Methods section “CRISPR-
Cas9-mediated 
perturbations” 
sequence-
based 
reagent 
gRNA 
Primer 2 
Hutchins 
and 
Bronner, 
2018 
PCR primer 
Detailed in Materials and 
Methods section “CRISPR-
Cas9-mediated 
perturbations” 
sequence-
based 
reagent 
Guide-
constant 
oligo 
Hutchins 
and 
Bronner, 
2018 
PCR primer 
Detailed in Materials and 
Methods section “CRISPR-
Cas9-mediated 
perturbations” 
commercial 
assay or kit 
Chromium 
Single Cell 
3’ Library & 
Gel Bead 
Kit v2 
10X 
Genomics Cat# PN-120267  
commercial 
assay or kit 
Chromium 
Single Cell 
A Chip Kit 
10X 
Genomics 
Cat# PN-
1000009 
 
 
commercial 
assay or kit 
Endofree 
maxi prep 
kit 
Macharey 
Nagel Cat# 740426.50  
commercial 
assay or kit 
Agencourt 
AMPure XP 
beads 
Beckman 
Coulter Cat# A63880  
commercial 
assay or kit 
Dynabeads 
MyOne 
SILANE 
10X 
Genomics Cat# 2000048  
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commercial 
assay or kit 
SPRIselect 
Reagent Kit 
Beckman 
Coulter Cat# B23318  
commercial 
assay or kit 
High 
Sensitivity 
DNA Kit 
Agilent Cat# 5067-4626 
 
commercial 
assay or kit 
Qubit 
dsDNA HS 
Assay Kit 
Thermo 
Fisher 
Scientific 
Cat# Q32854 
 
software, 
algorithm Fiji 
Schindelin 
et al., 
2012 
RRID: 
SCR_002285 https://imagej.net/Fiji 
software, 
algorithm Seurat 
Butler et 
al., 2018 
RRID: 
SCR_007322 https://satijalab.org/seurat/ 
software, 
algorithm Inkscape Inkscape 
RRID: 
SCR_014479 https://inkscape.org/ 
software, 
algorithm Cellranger 
10X 
Genomics   
software, 
algorithm 
2100 Expert 
software Agilent 
RRID: 
SCR_014466  
other Fluoromount-G 
Southern 
Biotech Cat# 0100-01  
other DAPI 
Thermo 
Fisher 
Scientific 
Cat# D1306 1:10000 on sections 
 618 
Electroporations 619 
 Chicken embryos (Gallus gallus) were commercially obtained from Sun Valley 620 
farms (CA), and developed to the specified Hamburger-Hamilton (HH) (Hamburger and 621 
Hamilton, 1951) stage in a humidified 37C incubator. For ex ovo electroporations, 622 
embryos were dissected from eggs at HH4, injected with specified reagents, then 623 
electroporated as described previously (Sauka-Spengler and Barembaum, 2008). 624 
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Following electroporation, embryos were cultured in fresh albumin/1% penicillin-625 
streptomycin at 37C and grown to specified HH stages. Once the embryos reached the 626 
desired stages, they were screened for transfection efficiency and overall health. 627 
Unhealthy and/or poorly transfected embryos were discarded and not included for 628 
downstream assays. 629 
 630 
Single-cell suspension  631 
HH4 embryos electroporated with FoxD3-NC2:eGFP were cultured until HH12 ex 632 
ovo at 37˚C, following which the hindbrain region spanning rhombomeres 6, 7, and 8 633 
was dissected under a fluorescence microscope. For dissociation, several different 634 
conditions were tested (dissociation in a glass dish for 1h in Accumax (EMD Millipore), 635 
chemical dissociation on a nutator for 15, 30, and 45 minutes, and chemical dissociation 636 
with gentle pipetting for 15, 30, and 45 minutes). The quality of the single cell 637 
suspension obtained was tested by a trypan blue-based live-dead staining. Accordingly, 638 
we pooled dissected tissue washed in chilled 1X DPBS and incubated it in Accumax cell 639 
dissociation solution for 15 minutes at 37°C with gentle mixing every 5 minutes. 640 
Dissociation was terminated using Hanks Buffered Saline Solution (HBSS) (Corning) 641 
supplemented with BSA Fraction V (Sigma; 0.2% w/v). The suspension was centrifuged 642 
at 300g for 4 minutes to collect cells at the bottom, the supernatant was removed, and 643 
the pellet was resuspended in 1mL HBSS-BSA. To remove cell debris and clumps, the 644 
1mL suspension was passed through a 20µm filter in a clean hood. This suspension 645 
was loaded on a 10X Chromium chip A (v2) to generate GEMs. The library was 646 
prepared according to the manufacturer’s protocol and sequenced on the Illumina 647 
HiSeq platform using the paired end chemistry. 648 
 649 
scRNA-seq data analysis 650 
The raw fastq files were aligned to the galgal6 (GRCg6a) genome assembly 651 
obtained from the ENSEMBL database using the cellranger pipeline downloaded from 652 
the 10X Genomics website. For feature counts, a custom galgal6 GTF file, where all 653 
annotated 3’ UTRs were extended by 1kb, was used. This was done to compensate for 654 
improper gene annotations in the chick genome. The count matrices were then imported 655 
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in R for analysis using Seurat (Butler et al., 2018). The initial filtering step discarded all 656 
cells with fewer than 200 and more than 10000 genes per cell. We also filtered out cells 657 
expressing more than 5% mitochondrial or less than 20% ribosomal genes. Next, we 658 
removed genes corresponding to small RNAs, micro RNAs, mitochondria, and general 659 
housekeeping from the count matrix. Following log normalization and Principal 660 
Component Analysis, the cells were clustered using the first 15 dimensions (calculated 661 
from the elbow plot). Different resolution parameter values were tested, and a value of 662 
0.45 was used to identify subpopulations within the data. Dimensional reductionality 663 
was performed using the UMAP (McInnes et al., 2018) algorithm. All plots were created 664 
in R, exported in SVG format, and assembled in Inkscape.  665 
 666 
Hybridization Chain Reaction 667 
HCR v3 was performed using the protocol suggested by Molecular Technologies 668 
(Choi et al., 2018) with minor modifications. Briefly, the embryos were fixed in 4% 669 
paraformaldehyde (PFA) overnight at 4˚C or 2h at room temperature, washed in 0.1% 670 
PBS-Tween, dehydrated in a series of 25%, 50%, 75%, and 100% methanol washes, 671 
and incubated overnight at -20˚C in 100% methanol. The next day, the embryos were 672 
rehydrated, treated with proteinase-K for 2-2.5 minutes, and incubated with 10pmol of 673 
probes dissolved in hybridization buffer overnight at 37˚C. The next day, following 674 
several washes in ‘probe wash buffer,’ embryos were incubated in 30pmol of hairpins 675 
H1 and H2 diluted in Amplification buffer at room temperature overnight. The next 676 
morning, embryos were washed in 0.1% 5x-SSC-Tween and imaged. All probes were 677 
designed and ordered through Molecular Technologies. 678 
 679 
Molecular cloning 680 
 The coding sequence of Hmga1 was obtained from the UCSC genome browser 681 
(Karolchik et al., 2003). A V5 tag was cloned in-frame at the N-terminus using overlap 682 
PCR (Accuprime). The fusion product was cloned downstream of the CAGG promoter, 683 
upstream of the IRES-H2B-RFP segment of pCI-H2B-RFP (Betancur et al., 2010) to 684 
clone the final plasmid (CAGG>V5-HMGA1-IRES-H2B-RFP). The Cas9 and gRNA 685 
constructs (Gandhi et al., 2017), neural crest enhancer FoxD3-NC2:eGFP (Simões-686 
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Costa et al., 2012), canonical Wnt reporter TCF/Lef:H2B-GFP (Ferrer-Vaquer et al., 687 
2010), and neural crest-specific stabilized ß-catenin NC1-∆90ß-cat (Hutchins and 688 
Bronner, 2018) have all been previously described and validated. 689 
 690 
CRISPR-Cas9-mediated perturbations 691 
The genomic locus for Hmga1 was obtained from the UCSC genome browser 692 
(Karolchik et al., 2003). Two gRNAs targeting the coding sequence, the first targeting 693 
exon 3 (5’-CCAGGAAGAAACCGGAGgta-3’), and the second targeting exon 4 (5’-694 
GCCAGCTCCAAAGGCAGGgt-3’), were designed using CHOPCHOP (Labun et al., 695 
2019). The protospacers were cloned downstream of the chick U6.3 promoter as 696 
described in Gandhi et al., 2017. For control electroporations, the control gRNA 697 
described in (Gandhi et al., 2017) was used. CAGG>nls-Cas9-nls and CAGG>H2B-RFP 698 
were electroporated at a concentration of 2µg/µl, together with either 0.75µg/µl per 699 
Hmga1 gRNA on the right side or 1.5µg/µl of control gRNA on the left side.  700 
For Cas9/in vitro-transcribed gRNA RNP experiments, we generated single-guide 701 
RNAs (sgRNAs) as described previously (Hutchins and Bronner, 2018), using the 702 
following primers: 703 
Hmga1.1 short guide oligo: 5’-704 
GCGTAATACGACTCACTATAGGCAGGAAGAAACCGGAGGTAGTTTTAGAGCTAGA705 
AATAGC-3’; Hmga1.2 short guide oligo: 5’-706 
GCGTAATACGACTCACTATAGGCCAGCTCCAAAGGCAGGGTGTTTTAGAGCTAGA707 
AATAGC; Control short guide oligo: 5’-708 
GCGTAATACGACTCACTATAGGCACTGCTACGATCTACACCGTTTTAGAGCTAGAA709 
ATAGC; gRNA Primer 1: 5’-CACGCGTAATACGACTCACTATAG; gRNA Primer 2: 5’-710 
AAAGCACCGACTCGGTGCCAC; Guide-constant oligo: 5’-711 
AAAGCACCGACTCGGTGCCACTTTTTCAAGTTGATAACGGACTAGCCTTATTTTAAC712 
TTGCTATTTCTAGCTCTAAAAC.  713 
2.6µl of recombinant Cas9 (M0646; New England Biolabs) was mixed with equal 714 
volumes of control gRNA or 1.3µl each of the two Hmga1 gRNAs, and heated to 37C 715 
for 15 minutes. The solution was then incubated at room temperature for 15 minutes, 716 
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mixed with 2µg/µl H2B-RFP and 1µl of sterilized 2% food dye, and injected in embryos 717 
for electroporation. 718 
 719 
In situ hybridization and immunohistochemistry  720 
Chromogenic in situ hybridization was performed as described previously for 721 
FoxD3, Sox10, and Tfap2b, c-Myc, and Wnt1 (Kerosuo and Bronner, 2016; Simoes-722 
Costa and Bronner, 2016; Simões-Costa et al., 2015).  723 
 Immunohistochemistry was performed as described previously (Gandhi et al., 724 
2017). Briefly, embryos were fixed for 20 minutes at room temperature, blocked in 10% 725 
goat or donkey serum in 0.5% PBS-Triton overnight at 4˚C, incubated overnight at 4˚C 726 
in primary antibodies diluted in blocking solution, washed at room temperature in 0.5% 727 
PBS-Triton, incubated overnight at 4˚C in secondary antibodies diluted in blocking 728 
solution, washed at room temperature in 0.5% PBS-Triton, and processed for imaging 729 
and/or cryosectioning. The following primary antibodies and concentrations were used: 730 
Mouse IgM HNK1 (1:5; Developmental Studies Hybridoma Bank (3H5)); Mouse IgG1 731 
Pax7 (1:10; Developmental Studies Hybridoma Bank (RRID:AB_528428)); Goat GFP 732 
(1:500; Rockland Cat# 600-101-215); Rabbit RFP (1:500; MBL Cat# PM005); Rabbit 733 
Snail2 (1:200; Cell Signaling Technology (9585)); Rabbit Laminin (1:1000; Sigma-734 
Aldrich (L9393)); Rabbit cleaved-Caspase 3 (1:500; R&D Systems Cat# AF835); Mouse 735 
phospho-histone H3 (1:500; Abcam Cat# Ab14955). The following species-specific 736 
secondary antibodies labeled with Alexa Fluor dyes (Invitrogen) were used: 737 
Goat/Donkey anti-Mouse Alexa Fluor 647 (for Pax7 and pH3; 1:250), Goat/Donkey Goat 738 
anti-Mouse IgM Alexa Fluor 350/488 (for HNK1; 1:250), Goat/Donkey anti-Rabbit Alexa 739 
Fluor 488 (for Snail2, cleaved-Caspase3, and Laminin; 1:250), Donkey anti-goat Alexa 740 
Fluor 488 (for Citrine; 1:500), and Goat/Donkey anti-rabbit Alexa Fluor 568 (for RFP; 741 
1:500). 742 
 743 
Cryosectioning 744 
Following whole mount imaging, embryos were washed in 5% and 15% sucrose 745 
overnight at 4˚C. The next day, embryos were transferred to molten gelatin for 3-5h at 746 
37˚C, embedded in molds at room temperature, frozen in liquid nitrogen, and stored at -747 
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80°C overnight. Embedded embryos were sectioned on a micron cryostat to obtain 748 
16µm sections through immunostained embryos and 20µm sections through in situ 749 
hybridized embryos. The sections were degelatinized at 42°C in 1x PBS for 5 minutes, 750 
washed in 1x PBS, soaked in 1x PBS containing 0.1µg/mL DAPI for 2 minutes, washed 751 
in 1x PBS and distilled water. Fluoromount mounting medium was used to mount 752 
coverslips on slides.  753 
 754 
Microscope image acquisition, analysis, and statistical tests 755 
Whole mount embryos and sections on slides were imaged on a Zeiss Imager M2 756 
with an ApoTome module and/or Zeiss LSM 880 confocal microscope at the Caltech 757 
Biological Imaging Facility. Images were post-processed using FIJI imaging software 758 
(Schindelin et al., 2012). To calculate corrected total cell fluorescence (CTCF), the 759 
following formula was used: 760 ܥܶܥ� = �݊ݐ݁݃ݎܽݐ݁݀ ܦ݁݊ݏ�ݐ� − ሺ݈ܵ݁݁ܿݐ݁݀ ܽݎ݁ܽ ∗ �݁ܽ݊ ܾܽܿ݇݃ݎ݋ݑ݊݀ ݂݈ݑ݋ݎ݁ݏܿ݁݊ܿ݁ሻ 
For cell counts, a median filter was applied to 8-bit images. A Bernsen-based auto 761 
local-thresholding method (Bernsen, 1986) followed by watershed segmentation was 762 
used to identify cell boundaries. The ‘Analyze particles’ function was used to count the 763 
number of cells. All statistical analyses were performed in R. The Wilcoxon rank test 764 
was used in datasets that were not normally distributed. In cases where the underlying 765 
distribution was normal, a student’s t-test was used to calculate significance. In cases 766 
where multiple samples were compared, Analysis of Variance (ANOVA) test combined 767 
with Tukey HSD correction was used. Post hoc power analysis was used to validate 768 
sample size and confirm sufficient statistical power (> 0.8)   769 
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Figure Legends 964 
 965 
Figure 1: Single-cell (sc) RNA-seq of hindbrain neural crest reveals known and 966 
novel transcriptional regulators. A. Schematic diagram illustrating the pipeline for 967 
performing scRNA-seq on the 10X Genomics platform. Reporter expression mediated 968 
by the FoxD3-NC2 enhancer (A’) was used as reference to dissect the hindbrain of 969 
HH12 chick embryos. Barcoded GEMs generated from the single-cell suspension were 970 
sequenced at a median depth of 50,000 reads/cell. B. Dimensional reduction using 971 
UMAP identifies 6 subpopulations (including the spike-in) contained within the 972 
dissociated embryonic hindbrain. C. Subset of B showing cells from hindbrain (Hb), 973 
ectoderm (Ect), and neural crest (NC). D-D’. Feature plots used to visualize the 974 
expression of known marker genes as a means of identifying subpopulations in (C) in 975 
low dimensional space. Single-cell expression distribution for marker genes (D’) in each 976 
cluster is shown as violin plots. E. Genes that were associated with the GO terms ‘DNA 977 
binding’, ‘regulation of transcription,’ or ‘transcription factor’ were characterized as 978 
transcriptional regulators and the relative expression and abundance of a subset of 979 
them was visualized as a dot plot. The size of each dot corresponds to the percentage 980 
of cells expressing that specific gene in a given cluster, while the color represents the 981 
average expression level. F. Feature plots showing expression of previously 982 
uncharacterized transcription factors or chromatin remodelers expressed in neural crest 983 
cells. G-K. Hybridization Chain Reaction was used to validate the expression of a few 984 
factors that were identified in (E). Dorsal view of the hindbrain of HH12 shows migratory 985 
neural crest streams at r4 and r6 surrounding the otic. Hb, hindbrain; ot, otic placode; r, 986 
rhombomere; nc, neural crest; ect, ectoderm.  987 
See also Figure 1 – figure supplement 1 and 2. 988 
 989 
Figure 1 – figure supplement 1: Quality of single cell RNA-seq dataset. A. Scatter 990 
plot shows high correlation between the number of unique genes and the total number 991 
of molecules detected in each cell. B-C. The distribution of total number of molecules 992 
(B) and number of unique genes (C) detected per cell across the 8 cell types identified 993 
within the chick hindbrain. D. Increasing the resolution parameter in the single-cell 994 
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analysis pipeline to calculate a cell’s ‘nearest neighbor’ allowed identification of three 995 
subpopulations within the ‘mesoderm’ cluster displayed in Figure 1B. Based on marker 996 
gene expression, these subpopulations were identified as mesoderm (Twist1+), paraxial 997 
mesoderm (Prrx1+), and myocardium (Hand2+). E. The expression of the top 10 most 998 
abundant genes from each subcluster was used to plot a heatmap, which also grouped 999 
into 8 distinct categories, similar to (D). A subset of these abundant genes are labeled 1000 
along the y-axis. 1001 
 1002 
Figure 1 – figure supplement 2: Identification of novel genes expressed in the 1003 
neural crest. A. Feature plots showing expression of marker genes in low-dimensional 1004 
space used to identify all 8 sub-clusters within the chick hindbrain. B. Violin plots 1005 
showing the distribution of expression of these marker genes (A) in surrounding cell 1006 
types. C. Relative expression of all genes expressed in the neural crest cluster that 1007 
share the GO terms ‘DNA binding’, ‘transcription factor’, and ‘regulation of transcription’. 1008 
Several of these genes are transcriptional regulators and/or chromatin remodelers that 1009 
are ubiquitously expressed in surrounding tissues. The radius of each point reflects the 1010 
proportion of cells within individual clusters that express a specific gene, whereas the 1011 
relative expression is reflected by the color of the point (grey – low/negative expression, 1012 
blue – high expression). A subset of these genes are highlighted in Figure 1E. 1013 
 1014 
Figure 2: Hmga1 is expressed in the neural plate, neural plate border, and 1015 
premigratory and migratory neural crest cells. A. HCR against Hmga1 at HH5 1016 
reveals expression in the neural plate and neural plate border. B-B’. A wildtype HH6 1017 
chick embryo double-labeled with Hmga1 (B) and Pax7 (B’) probes. Hmga1 expression 1018 
overlaps with Pax7 in the neural plate border. B’’-B’’’. Transverse section through 1019 
embryo in (B) shows Hmga1 and Pax7 transcripts in the neural plate and neural plate 1020 
border, respectively, but not the non-neural ectoderm. C-D’. As the neural folds elevate, 1021 
Hmga1 expression is retained in the dorsal neural tube. D’’-D’’’. Transverse section 1022 
through embryo in (D) shows Hmga1 transcripts in the neural tube. E-F. As neural crest 1023 
cells delaminate (E’’’) and migrate laterally from the neural tube (F’’’), Hmga1 is 1024 
expressed in emigrating (E’’) and migrating neural crest cells (F’’), along with Pax7 (E’ 1025 
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and F’). Arrow points towards delaminating (E’’) and migrating (F’’) cranial neural crest 1026 
cells. hn, Hensen’s node; npb, neural plate border; np, neural plate; nne, non-neural 1027 
ectoderm; ect, ectoderm; dNF, dorsal neural folds; nc, notochord; nt, neural tube.  1028 
See also Figure 2 – figure supplement 1. 1029 
 1030 
Figure 2 – figure supplement 1: Overlapping expression of Hmga1 and Pax7 in the 1031 
neural crest visualized in individual channels. A-H. Transverse sections shown in 1032 
Figure 2 stained with DAPI (A,C,E,G). The expression of Hmga1 and Pax7 overlapped 1033 
in the neural plate border (B,B’; arrows), dorsal neural folds (D,D’; arrows), premigratory 1034 
(F,F’; arrows), and migratory neural crest cells (H,H’; arrows).  1035 
 1036 
Figure 3: Hmga1 knockout results in loss of neural crest specification. A. The 1037 
electroporation strategy for knocking out Hmga1 using CRISPR-Cas9 in gastrula stage 1038 
chick embryos. B. Electroporated embryos were allowed to develop until HH9+ and 1039 
screened for the expression of H2B-RFP. C. Electroporation of Cas9 and Hmga1 1040 
gRNAs on the right side resulted in loss of Hmga1 transcripts in the neural crest as 1041 
confirmed using HCR. D. Hmga1 expression in the neural crest quantified as corrected 1042 
total cell fluorescence (CTCF) intensity in wholemount Hmga1-mutant embryos 1043 
processed for HCR. A significant reduction in expression was observed (p-value < 0.05, 1044 
Wilcoxon rank test) on the experimental compared to the control side. A ratio of 1 1045 
(dotted line) corresponds to similar levels of Hmga1 expression on both sides. E-F. 1046 
Hmga1 knockout results in reduced Pax7 expression in the neural crest, likely resulting 1047 
from a significant reduction in Pax7+ cell count (F) on the knockout compared to the 1048 
control side (**** p<0.0001, student’s t-test). G-H. Transverse section through the 1049 
hindbrain of a representative knockout embryo (G’) was stained for Pax7 (H) and the 1050 
neural crest specifier Snail2 (H’). I. Hmga1 knockout also resulted in a reduction of Pax7 1051 
transcripts on the knockout side. J-L. Hmga1-mutant embryos were processed for in 1052 
situ hybridization against neural crest specifier genes FoxD3 (J, J’), Tfap2b (K), and 1053 
Sox10 (L, L’). M. Transverse section through a representative embryo probed for the 1054 
expression of Sox10 showed reduced expression of the migratory neural crest marker, 1055 
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HNK1. The expression of Pax7 (M’) was also reduced, while the thickness of the neural 1056 
tube remained unchanged (M’’).  1057 
See also Figure 3 – figure supplement 1; Figure 3 – source data 1, Figure 3 – source 1058 
data 2. 1059 
 1060 
Figure 3 – figure supplement 1: Knocking out Hmga1 in gastrula stage embryos. 1061 
A. The genomic locus of Hmga1 in the chick genome. Two gRNAs, one targeting the 1062 
splice donor site of exon 3 and another one targeting the splice donor site of exon 4 1063 
were designed to knock it out using CRISPR-Cas9. The protospacer adjacent motifs for 1064 
both gRNAs lie in the intronic regions (highlighted in blue). B. Electroporated embryos 1065 
were allowed to develop until HH9+ and immunostained for the migratory neural crest 1066 
marker HNK1. In the absence of Hmga1, neural crest cells failed to migrate properly on 1067 
the experimental side. C. Hmga1 knockout results in reduced c-Myc expression in 1068 
premigratory neural crest. D-E’’. Transverse section through a representative Hmga1-1069 
knockout embryo with FoxD3 mRNA labeled using in situ hybridization. Neural crest 1070 
cells migrated normally on the control (arrow) compared to the knockout side (asterisk). 1071 
While the thickness of the neural tube (E) was unaffected on the knockout side, the 1072 
expression of Pax7 (E’) and HNK1 (E’’) was also reduced. 1073 
 1074 
Figure 3 – source data 1: Hmga1 HCR intensity whole mount embryos compared 1075 
between Control and Hmga1-knockout sides in panel C. 1076 
 1077 
Figure 3 – source data 2: Pax7-positive cell counts in whole mount embryos 1078 
compared between Control and Hmga1-knockout sides in panel G.  1079 
 1080 
Figure 4: The effects of Hmga1 knockout on neural crest specification are Pax7-1081 
dependent. A-B. Transverse sections through a representative embryo show a 1082 
dramatic reduction in the number of Pax7+ cells in the hindbrain (B, asterisk) as 1083 
compared to the midbrain (A) at HH9/9+. As the hindbrain develops later than the 1084 
midbrain due to the anterior-posterior progression of neural development, the effect on 1085 
neural crest specification is more penetrant in the hindbrain (asterisk) due to the time 1086 
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lag between Cas9 plasmid electroporation and its activation in transfected cells. C. The 1087 
ratio of Pax7+ cells between the experimental and control sides quantified at the 1088 
midbrain and hindbrain levels is significantly different (* p<0.05; student’s t-test). A ratio 1089 
of 1 (dotted line) corresponds to a similar number of Pax7+ cells on both sides. D. 1090 
Electroporation strategy for knocking out Hmga1 using Cas9 protein and in vitro-1091 
transcribed gRNAs. This strategy was used to immediately reduce the levels of Hmga1 1092 
on the knockout side. E. HCR against Hmga1 in mutant embryos shows dramatic 1093 
transcriptional reduction on the experimental side (arrowhead). F. Cas9-protein-1094 
mediated loss of Hmga1 resulted in downregulation of Pax7 expression in the neural 1095 
plate border on the right side (experimental side; arrowhead). G. Illustration of the 1096 
neural plate border. H-I’. Transverse section through embryo shown in F. 1097 
Electroporation of the control ribonucleoprotein (RNP) complex had no effect on the 1098 
expression of Pax7 in the neural plate border (H), whereas the knockout side showed 1099 
an almost complete loss (I, asterisk). No difference in the thickness of the neural plate 1100 
border was observed between the two sides (H’,I’). J. Quantification of relative 1101 
fluorescence intensity for Pax7 signal calculated as corrected total cell fluorescence 1102 
(C.T.C.F) revealed a statistically significant difference between the control (left) and 1103 
knockout (right) sides (** p<0.01, paired student’s t-test). K-P’’. Representative Hmga1-1104 
mutant embryos that were processed for HCR against neural plate border genes Tfap2a 1105 
(K; experimental side - arrowhead) and Msx1 (N; experimental side - arrowhead). While 1106 
Hmga1 loss resulted in reduction of Pax7 transcripts on the experimental sides (M,P; 1107 
asterisk) compared to the control sides (L,O), the expression of Tfap2a (L’,M’) and Msx1 1108 
(O’,P’) was relatively unchanged. No notable difference was observed in the thickness 1109 
of the neural plate border (L’’,M’’,O’’,P’’). Q. Transcriptional response to the loss of 1110 
Hmga1 was quantified as the ratio of knockout versus control C.T.C.F per unit area. 1111 
While Pax7 expression was significantly reduced (*** p<0.001, paired student’s t-test), 1112 
no significant difference in Msx1 expression was observed (n.s. p>0.05, paired student’s 1113 
t-test). Dotted line represents unperturbed ratio.  1114 
See also Figure 4 – figure supplement 1; Figure 4 – source data 1, Figure 4 – source 1115 
data 2, Figure 4 – source data 3. 1116 
 1117 
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Figure 4 – figure supplement 1: Hmga1 knockout does not affect neural crest cell 1118 
proliferation and apoptosis. A. Whole mount embryo shown in Figure 4F. Nuclear 1119 
RFP was electroporated as a transfection control. B-G’. Adjacent transverse sections 1120 
through embryo in A immunostained with antibodies against phospho-histone H3 1121 
(B,C’,D’) and cleaved-caspase-3 (E,F’,G’) as a readout for cell proliferation and 1122 
apoptosis, respectively. While the levels of Pax7 protein (C,D,F,G) were downregulated 1123 
in the absence of Hmga1, no notable difference was observed in the rate of proliferation 1124 
or cell death between the experimental (right; D’,G’) and control (left; C’,F’) sides. H. 1125 
The relative fluorescence intensity for Pax7, cleaved-caspase-3, and phospho-histone 1126 
H3 was measured as the ratio of corrected total cell fluorescence (C.T.C.F.) between 1127 
the knockout versus the control side. The Pax7 fluorescence intensity was significantly 1128 
reduced (** p<0.01, paired Student’s t-test) on the knockout side, whereas the 1129 
difference between cleaved-caspase-3 and phospho-histone H3 relative intensities was 1130 
not significant (n.s. p>0.05, paired Student’s t-test). Dotted line represents unperturbed 1131 
ratio. 1132 
See also Figure 4 – figure supplement 1 – source data 1. 1133 
 1134 
Figure 4 – source data 1: Pax7-positive cell counts in transverse sections through 1135 
the midbrain and hindbrain compared between Control and Hmga1-knockout 1136 
sides in panel C. 1137 
 1138 
Figure 4 – source data 2: Pax7 corrected total cell fluorescence intensity in 1139 
transverse sections through the neural plate border compared between Control 1140 
and Hmga1-RNP-knockout sides in panel J. 1141 
 1142 
Figure 4 – source data 3: Pax7 and Msx1 HCR corrected total cell fluorescence 1143 
intensity in transverse sections through the neural plate border compared 1144 
between Control and Hmga1-RNP-knockout sides in panel Q.  1145 
 1146 
Figure 4 – figure supplement 1 – source data 1: Pax7, Cleaved-caspase-3, and 1147 
phospho-histone-H3 corrected total cell fluorescence intensity in transverse 1148 
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sections through the neural plate border compared between Control and Hmga1-1149 
RNP-knockout sides in panel H. 1150 
 1151 
Figure 5: Ectopic expression of Hmga1 or Pax7 rescues cranial neural crest 1152 
specification. A. Plasmid construct used to rescue Hmga1. An independent ribosome 1153 
entry site (IRES) controls translation of nuclear RFP in transfected cells. The 1154 
electroporation strategy for knocking out Hmga1 using CRISPR-Cas9 in gastrula stage 1155 
chick embryos. B. Embryos were electroporated with the ‘rescue’ construct on the right 1156 
side and a control nuclear RFP plasmid on the left side. C. Exogenous expression of the 1157 
Hmga1 coding sequence under the regulation of a ubiquitous enhancer/promoter 1158 
combination causes cranial neural crest migration defects. D-G’’’. Overexpression of 1159 
the coding sequence (G’’’) of Hmga1 compensates for its loss of function, rescuing 1160 
proper cranial neural crest migration (D), as assayed by number of Pax7-positive neural 1161 
crest cells (E), and expression of the neural crest specifier gene Sox10 (F) in migratory 1162 
cranial neural crest (G,G’) and Pax7 in the dorsal neural tube (G’’). Electroporated 1163 
embryos were allowed to develop until HH9+ and screened for the expression of H2B-1164 
RFP. H-H’. The coding sequence for Pax7 was ectopically expressed in an Hmga1-1165 
knockout background. Transverse section through a representative embryo shows the 1166 
comparison between endogenous (left) and overexpressed (right; arrow) Pax7 transcript 1167 
levels in the dorsal neural tube. I-K. Ectopic expression of Pax7 rescued neural crest 1168 
specification defects caused by the loss of Hmga1 as assayed by the expression of 1169 
neural crest specifier genes Tfap2b (I) and Snai2 (I’) in transverse cross-sections 1170 
through the hindbrain (J,K). nt, neural tube; nc, notochord. 1171 
See also Figure 5 – source data 1. 1172 
 1173 
Figure 5 – source data 1: Pax7-positive cell counts in transverse sections through 1174 
the hindbrain compared between Control and Hmga1-rescue sides in panel E. 1175 
 1176 
Figure 6: Hmga1 activates Wnt signaling pathway in delaminating neural crest 1177 
cells. A. Plasmid construct used as a readout for Wnt activity (after Ferrer-Vaquer et al., 1178 
2010). Six TCF/Lef binding sites together with a minimal promoter regulate the 1179 
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expression of nuclear GFP in transfected cells in response to Wnt signaling. B. 1180 
Transverse section through the midbrain of a representative HH9+ embryo 1181 
immunostained for Pax7, GFP, RFP, and DAPI. C-C’’. Individual channels of image in B 1182 
focused on the dorsal neural tube. In the absence of Hmga1, Wnt reporter activity was 1183 
downregulated, resulting in fewer cells that expressed nuclear GFP (arrowheads) on the 1184 
right side (C), even though cells were uniformly transfected on both experimental and 1185 
control sides (C’), and the thickness of the neural tube remained unaffected (C’’). D. The 1186 
reduction in Wnt reporter output was quantified as a ratio of number of cells that 1187 
expressed nuclear GFP, and the number of cells that were successfully transfected and 1188 
therefore expressed nuclear RFP. The observed difference in GFP+/RFP+ ratio 1189 
between the knockout and control sides was statistically significant (** p<0.01, student’s 1190 
t-test). E-F. In situ hybridization against Wnt1 in an Hmga1-knockout background. 1191 
Transverse section through the midbrain (E) and hindbrain (F) shows reduced and 1192 
unchanged levels of Wnt1 ligand in the dorsal neural tube on the experimental (arrow) 1193 
versus control neural tubes, respectively. E’-F’. The number of Pax7-positive cells in the 1194 
midbrain appeared unchanged (E’), while a reduction was observed in the hindbrain 1195 
(F’). G-H. Transverse section through a representative embryo where Hmga1 was 1196 
knocked out using CRISPR plasmids (G), and an embryo where Draxin was ectopically 1197 
expressed (H) on the right side, immunostained for Laminin. Similar to Draxin 1198 
overexpression, Hmga1 loss resulted in a failure of basement membrane remodeling 1199 
due to reduced canonical Wnt signaling in neural crest cells, causing the laminin 1200 
channel to remain blocked on the experimental side (arrows). I-J. Expression of 1201 
stabilized ß-catenin (NC1-∆90ß-cat) in delaminating cranial neural crest of Hmga1-1202 
knockout embryos was sufficient to rescue the migration defect. K. Quantification of 1203 
area covered by cranial neural crest cells on the experimental versus control sides. In 1204 
the absence of Hmga1, cranial neural crest cells fail to migrate properly, a defect that 1205 
can be separately rescued in Hmga1-knockout background by overexpression (OE) of 1206 
stabilized ß-catenin in delaminating cranial neural crest, or exogenous expression of 1207 
Hmga1 coding sequence ectopically (Rescue). nt, neural tube; nc, notochord; KO, 1208 
knockout; OE, overexpression.  1209 
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See also Figure 6 – figure supplement 1, Figure 6 – source data 1, Figure 6 – source 1210 
data 2. 1211 
 1212 
Figure 6 – figure supplement 1: Hmga1 regulates Wnt1 expression in 1213 
premigratory cranial neural crest cells. A. Genomic locus of Wnt1 obtained from the 1214 
UCSC genome browser (Karolchik et al., 2003). ATAC-seq profile of premigratory 1215 
cranial neural crest cells (from Williams et al., 2019) shows a putative Wnt1 enhancer 1216 
upstream of the gene (highlighted in red). B. Genomic sequence of the putative 1217 
enhancer identified in (A) contains a predicted AT-rich Hmga1 binding motif (red box). 1218 
C. A representative Hmga1-knockout embryo immunostained for Pax7 shows a 1219 
migration defect on the experimental side (right) compared to the control side (left). D. 1220 
The area covered by migratory cranial neural crest cells, marked by the position of the 1221 
lateral-most leader cell, is reduced following Hmga1 knockout (green – control; 53.3 1222 
a.u.2, magenta – knockout; 40.5 a.u.2). An overlay of the two areas highlights this 1223 
reduction. E. Transverse section through the embryo shown in (C). The number of 1224 
dorsal neural tube cells positive for canonical Wnt activity, as indicated by the nuclear 1225 
GFP reporter expression (E), was significantly decreased following the loss of Hmga1 1226 
(shown in figure 6C). However, the number of Pax7+ cells (E’) on either side of the 1227 
dorsal neural tube were relatively similar, despite the observed migration defect in (C). 1228 
No difference in the thickness of the neural tube (E’’) was observed (shown in figure 1229 
6C’’). 1230 
 1231 
Figure 6 – source data 1: Ratio of Tcf/Lef:GFP-positive and RFP-positive cell 1232 
counts in transverse sections through the midbrain compared between Control 1233 
and Hmga1-knockout sides in panel D.  1234 
 1235 
Figure 6 – source data 2: Ratio of neural crest cell migration area between 1236 
experimental and control sides in whole mount embryos compared between 1237 
Hmga1-knockout, ß-catenin-overexpression, and Hmga1-rescue conditions in 1238 
panel K. 1239 
 1240 
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Figure 7: Current model for Hmga1 function in chick neural crest development. 1241 
Our data suggest that Hmga1 plays temporally distinct roles in the neural plate border 1242 
and dorsal neural tube. At the neural plate border, Hmga1 acts upstream of Pax7 and is 1243 
required for proper neural crest specification. Later, in the dorsal neural tube, Hmga1 1244 
regulates the levels of Wnt1, thereby modulating the levels of canonical Wnt signaling to 1245 
control neural crest delamination and subsequent migration. 1246 
 1247 













